Ignite Creation Date:
2025-12-24 @ 10:40 PM
Ignite Modification Date:
2026-02-17 @ 5:24 PM
Study NCT ID:
NCT05803135
Status:
NOT_YET_RECRUITING
Last Update Posted:
2023-04-07
First Post:
2023-03-26
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Iguratimod Combined With Tofacitinib in the Treatment of Rheumatoid Arthritis
Sponsor:
Nanfang Hospital, Southern Medical University
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
NFEC-2022-282
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |